EUVIMEDEUVIMED entdecken
Crossref

Intranasal racemic ketamine for patients hospitalized with treatment-resistant depression: A retrospective analysis.

Evyn M Peters iD, Katelyn Halpape, Isaac Cheveldae, Annabelle Wanson

Experimental and Clinical Psychopharmacology · 2023-06 · 31 (3) · 593-598

DOI: 10.1037/pha0000627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Psychopharmacology, 2023-06. Verfasst von Evyn M Peters und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Saskatchewan. Hauptthemen laut MEDLINE: Ketamine, Major Depressive Disorder. Die Arbeit wurde bisher 10-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineMajor Depressive DisorderHumansAntidepressive AgentsDepressionRetrospective StudiesAnalgesicsAdministration, Intranasal

Substanzen

KetamineAntidepressive AgentsAnalgesics

Autor:innen und Institutionen

  • Department of Psychiatry, University of Saskatchewan.
  • College of Pharmacy and Nutrition, University of Saskatchewan.

ORCID-Profile: Evyn M Peters

Zitieren

APA

Peters, E. M., Halpape, K., Cheveldae, I., & Wanson, A. (2023). Intranasal racemic ketamine for patients hospitalized with treatment-resistant depression: A retrospective analysis. Experimental and Clinical Psychopharmacology, 31(3), 593-598. https://doi.org/10.1037/pha0000627

Vancouver

Peters EM, Halpape K, Cheveldae I, Wanson A. Intranasal racemic ketamine for patients hospitalized with treatment-resistant depression: A retrospective analysis. Experimental and Clinical Psychopharmacology. 2023;31(3):593-598. doi:10.1037/pha0000627

BibTeX
@article{Peters2023,
  author = {Peters, Evyn M and Halpape, Katelyn and Cheveldae, Isaac and Wanson, Annabelle},
  title = {Intranasal racemic ketamine for patients hospitalized with treatment-resistant depression: A retrospective analysis},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2023},
  volume = {31},
  number = {3},
  pages = {593--598},
  doi = {10.1037/pha0000627}
}
Kostenlos starten →